Faculty Profile

Kyle Hogarth
Section of Pulmonary / Critical Care
Professor of Medicine
Referring Physician Access Line: 1-877-DOM-2730

Academic Interests

Dr. Hogarth is involved with the minimally invasive diagnosis, management, staging, and treatment of lung cancer through bronchoscopy. Dr. Hogarth was one of the first doctors in Illinois to work with the superDimension system -- an electromagnetic navigation system that uses 3-D imaging technology to detect and biopsy nodules and masses and he was the first physician in the United States to utilize the Auris Monarch platform, a robotic bronchoscope. He uses endobronchial ultrasound to biopsy lymph nodes, place stents in cancerous airways, and perform all other minimally invasive techniques to help patients with lung cancer. Dr. Hogarth was the first physician in Illinois to perform bronchial thermoplasty, a new FDA-approved technique to treat severe asthma. He has done the most cases in Illinois and has authored numerous publications on this topic. Dr. Hogarth's research focuses on improving quality of life and outcomes for patients with AAT deficiency and lung cancer. He is an investigator in numerous clinical trials for these diseases and for bronchoscopy technologies. Dr. Hogarth is the current president of the Society for Advanced Bronchoscopy.

Clinical Interests

Bronchoscopy, Interventional Bronchoscopy, Lung Nodules, Alpha One Antitrypsin Deficiency


  • Hogarth DK. Use of augmented fluoroscopic imaging during diagnostic bronchoscopy. Future Oncol. 2018 Apr 17
  • Akthar AS, Koshy M, Ferguson MK, Murgu S, Hogarth DK, Golden DW, Connell PP, Davies EM, Kowalski E, Malik R .Effect of Endoscopic Bronchial Ultrasound on Outcomes for Stage I Non-Small-Cell Lung Cancer Patients Receiving Hypofractionated Radiotherapy. Clin Lung Cancer. 2018 Mar;19(2):e227-e233
  • White SR, Nicodemus-Johnson J, Laxman B, Denner DR, Naureckas ET, Hogarth DK, Stern R, Minc A, Solway J, Sperling A, Ober C .Elevated levels of soluble humanleukocyte antigen-G in the airways are a marker for a low-inflammatory endotype of asthma.J Allergy Clin Immunol. 2017 Sep;140(3):857-860
  • Laxmanan B, Egressy K, Murgu SD, White SR, Hogarth DK .Advances in Bronchial Thermoplasty. Chest. 2016 Sep;150(3):694-704
  • Morris S, Vachani A, Pass HI, Rom WN, Ryden K, Weiss GJ, Hogarth DK, Runger G, Richards D, Shelton T, Mallery DW. Whole blood FPR1 mRNA expression predicts both non-small cell and small cell lung cancer. Int J Cancer. 2018 Jun 1;142(11):2355-2362.
For a complete list of publications click here:


  • BA, 1994, Miami University, Microbiology, Chemistry, Zoology
  • MD, 1998, Case Western Reserve University,
  • Residency, 2001, The University of Chicago, Internal Medicine
  • Fellowship, 2004, The University of Chicago, Pulmonary and Critical Care